Praxis Precision Medicines, Inc.
PRAX
$37.32
-$1.10-2.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.12M | 8.55M | 1.61M | 1.77M | 2.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.12M | 8.55M | 1.61M | 1.77M | 2.20M |
| Cost of Revenue | 186.24M | 152.41M | 114.51M | 89.89M | 88.25M |
| Gross Profit | -178.11M | -143.86M | -112.91M | -88.12M | -86.05M |
| SG&A Expenses | 54.89M | 56.31M | 51.11M | 44.58M | 44.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 241.13M | 208.72M | 165.62M | 134.47M | 132.36M |
| Operating Income | -233.01M | -200.17M | -164.02M | -132.70M | -130.17M |
| Income Before Tax | -212.56M | -182.82M | -151.02M | -123.74M | -125.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -212.56 | -182.82 | -151.02 | -123.74 | -125.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -212.56M | -182.82M | -151.02M | -123.74M | -125.38M |
| EBIT | -233.01M | -200.17M | -164.02M | -132.70M | -130.17M |
| EBITDA | -232.71M | -199.81M | -163.59M | -132.26M | -129.73M |
| EPS Basic | -10.71 | -10.27 | -10.30 | -10.27 | -15.92 |
| Normalized Basic EPS | -6.78 | -6.46 | -6.44 | -6.42 | -9.95 |
| EPS Diluted | -10.71 | -10.27 | -10.30 | -10.27 | -15.92 |
| Normalized Diluted EPS | -6.78 | -6.46 | -6.44 | -6.42 | -9.95 |
| Average Basic Shares Outstanding | 78.75M | 71.59M | 60.67M | 50.83M | 36.65M |
| Average Diluted Shares Outstanding | 78.75M | 71.59M | 60.67M | 50.83M | 36.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |